Plasminogen Activator Inhibitor-1 Promotes Synaptogenesis and Protects Against Aβ_1-42-Induced Neurotoxicity in Primary Cultured Hippocampal Neurons

REFERENCES

• Gravanis I, Tsirka SE. Tissue plasminogen activator and glial function. Glia. 2005;49(2):177–83.
   PubMedGoogle Scholar
• Hultman K, Blomstrand F, Nilsson M, Wilhelmsson U, Malmgren K, Pekny M, Kousted T, Jern C, Tjärnlund-Wolf A. Expression of plasminogen activator inhibitor-1 and protease nexin-1 in human astrocytes: response to injury-related factors. J Neurosci Res. 2010;88(11):2441–9.
   PubMedGoogle Scholar
• Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998;4(2):228–31.
   PubMedGoogle Scholar
• Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 2001;7(1):59–64.
   PubMedGoogle Scholar
• Docagne F, Nicole O, Gabriel C, Fernandez-Monreal M, Lesne S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D. Smad3-depedent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol Cell Neurosci. 2002;21(4):634–44.
   PubMedGoogle Scholar
• Kruithof EK. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost. 2008;100(6):969–75.
   PubMedGoogle Scholar
• Nagamine Y. Transcriptional regulation of the plasminogen activator inhibitor type 1—with an emphasis on negative regulation. Thromb Haemost. 2008;100(6):1007–13.
   PubMedGoogle Scholar
• Booth GE, Kinrade EF, hidalgo A. Glia maintain follower neuron survival during Drosophila CNS development. Development. 2000;127:237–44.
   PubMedGoogle Scholar
• Quincozes-Santos A, Gottfried C. Resveratrol modulates astroglial functions: neuroprotective hypothesis. Ann N Y Acad Sci. 2011;1215:72–8.
   PubMedGoogle Scholar
• Pfrieger FW, Barres BA. Synaptic efficacy enhanced by glial cells in vitro. Science. 1997;277:1684–7.
   PubMedGoogle Scholar
• Guizzetti M, Moore NH, Giordano G, Costa LG. Modulation of neuritogenesis by astrocyte muscarinic receptors. J Biol Chem. 2008;183:31884–97.
   Google Scholar
• Galliciotti G, Sonderergger P. Neuroserpin. Front Biosci. 2006;11:33–45.
   PubMedGoogle Scholar
• Kinghorn KJ, Crowther DC, Sharp LK, Nerelius C, Davis RL, Chang HT, Green C, Gubb DC, Johansson J, Lomas DA. Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease. J Biol Chem. 2006;281(39):29268–77.
   PubMedGoogle Scholar
• Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs. 2009;14:67–84.
   PubMedGoogle Scholar
• Clare R, King VG, Wirenfeldt M, Vinters HV. Synapse loss in dementias. J Neurosci Res. 2010;88(10):2083–90
   PubMedGoogle Scholar
• Jang DJ, Park SW, Kaang BK. The role of lipid binding for the targeting of synaptic proteins into synaptic vesicles. BMB Rep. 2009;42(1):1–5.
   PubMedGoogle Scholar
• Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR. Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol. 1996;25(12):821–8.
   PubMedGoogle Scholar
• Ujike H, Takaki M, Kodama M, Kuroda S. Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann N Y Acad Sci. 2002;965:55–67.
   PubMedGoogle Scholar
• Hunt CA, Schenker LJ, Kennedy MB, PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses. J Neurosci. 1996;16 (4):1380–8.
   PubMedGoogle Scholar
• Gascon E, Vutskits L, Kiss JZ. Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev. 2007;56:101–18.
   PubMedGoogle Scholar
• Checler F, Suh YH. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev. 2000;54(3):469–525.
   Google Scholar
• Chotard C, Salecher I. Neurons and glia: team players in axon guidance. Trends Neurosci. 2004;27:655–61.
   PubMedGoogle Scholar
• Elmariah SB, Hughes EG, Oh EJ, Balice-Gordon RJ. Neurotrophin signaling among neurons and glia during formation of tripartite synapses. Neuron Glia Biol. 2005;1:1–11.
   Google Scholar
• Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14:2919–37.
   PubMedGoogle Scholar
• Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2001;2:24–32.
   PubMedGoogle Scholar
• Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci. 2004;5:771–81.
   PubMedGoogle Scholar
• Han K, Kim E. Synaptic adhesion molecules and PSD-95. Prog Neurobiol. 2008;84:263–83.
   PubMedGoogle Scholar
• Bastrikova N, Gardner GA, Reece JM, Jeromin A, Dudek SM. Synapse elimination accompanies functional plasticity in hippocampal neurons. Proc Natl Acad Sci USA. 2008;105(8):3123–7.
   PubMedGoogle Scholar
• Kawahara M, Ohtsuka I, Yokoyama S, Kato-Negishi M, Sadakane Y. Membrane incorporation, channel formation, and disruption of calcium homeostasis by Alzheimer's β-amyloid protein. Int J Alzheimers Dis. 2011;2011:304583.
   PubMedGoogle Scholar
• Axelsen PH, Komatsu H, Murray IV. Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease. Physiology (Bethesda). 2011;26(1):54–69.
   PubMedGoogle Scholar
• Costa RO, Ferreiro E, Martins I, Santana I, Cardoso SM, Oliveira CR, Pereira CM. Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions. Neurobiol Aging. 2012;33(4):824.e5–16.
   Google Scholar
• Wilcox KC, Lacor PN, Pitt J, Klein WL. Aβ oligomer-induced synapse degeneration in Alzheimer's disease. Cell Mol Neurobiol. 2011;31(6):939–48.
   PubMedGoogle Scholar
• Tran TT, Srivareerat M, Alhaider IA, Alkadhi KA. Chronic psychosocial stress enhances long-term depression in a subthrehold amyloid-beta rat model of Alzheimer's disease. J Neurochem. 2011;119:408–16.
   PubMedGoogle Scholar
• O'Leary OF, Wu X, Castren E. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signaling. Psychoneuroendocrinology. 2009;34:367–81.
   PubMedGoogle Scholar
• Chen X, Vinade L, Leapman RD, Petersen JD, Nakagawa T, Phillips TM, Sheng M, Reese TS. Mass of the postsynaptic density and enumeration of three key molecules. Proc Natl Acad Sci USA. 2005;102:11551–6.
   PubMedGoogle Scholar
• Bukhari N, Torres L, Robinson JK, Tsirka SE. Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system. J Neurosci. 2011;31(42):14931–43.
   PubMedGoogle Scholar